Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.

Sriyapai, Tatpong; Thongyai, Kanthong; Phuakpet, Kamon; Vathana, Nassawee; Buaboonnam, Jassada; Sanpakit, Kleebsabai

Sriyapai, Tatpong; Thongyai, Kanthong; Phuakpet, Kamon; Vathana, Nassawee; Buaboonnam, Jassada; Sanpakit, Kleebsabai.

Affiliation

Sriyapai T; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Thongyai K; Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Phuakpet K; Division of Pediatric Hematology and Oncology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Vathana N; Division of Pediatric Hematology and Oncology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Buaboonnam J; Division of Pediatric Hematology and Oncology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Sanpakit K; Division of Pediatric Hematology and Oncology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.

Turk J Pediatr ; 64(3): 531-541, 2022.

Article in En | MEDLINE | ID: mdl-35899566

Subject(s)
Key words

cisplatin; long-term; oncology; ototoxicity; pediatric

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ototoxicity / Hearing Loss / Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Child / Humans Country/Region as subject: Asia Language: En Journal: Turk J Pediatr Year: 2022 Document type: Article Affiliation country: Tailandia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google